Form 10-Q - Quarterly report [Sections 13 or 15(d)]

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2023

OR

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number 001-39608

INTRUSION INC.

(Exact name of registrant as specified in its charter)

Delaware	75-1911917
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

101 East Park Blvd, Suite 1200, Plano, Texas 75074

(Address of principal executive offices)

(Zip Code)

(972) 234-6400

(Registrant’s telephone number, including area code)

(Former name, former address and former fiscal year, if changed since last report)

* * * * * * * * * *

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.01 per share	INTZ	Nasdaq Capital Market

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes ☒ No ☐

Indicate by check mark whether the registrant is a large, accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large, accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large, accelerated filer	☐	Accelerated filer	☐
Non-accelerated Filer	☒	Smaller reporting company	☒
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): Yes ☐ No ☒

The number of shares outstanding of the Registrant’s Common Stock, $0.01 par value, on August 11, 2023, was 23,134,011.

INTRUSION INC.

INDEX

PART I – FINANCIAL INFORMATION

Item 1. Financial Statements	3

Condensed Consolidated Balance Sheets as of June 30, 2023 (unaudited) and December 31, 2022	3

Unaudited Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2023, and 2022	4

Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Deficit for the three and six months ended June 30, 2023, and 2022	5

Unaudited Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2023, and 2022	6

Notes to Unaudited Condensed Consolidated Financial Statements	7

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	18

Item 4. Controls and Procedures	23

PART II – OTHER INFORMATION	24

Item 1. Legal Proceedings	24

Item 1A. Risk Factors	25

Item 2. Unregistered Sale of Equity Securities and Use of Proceeds	26

Item 6. Exhibits	26

Signature Page	27

PART I – FINANCIAL INFORMATION

Item 1. FINANCIAL STATEMENTS

INTRUSION INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except par value amounts)


	June 30, 2023			December 31, 2022
	(unaudited)
ASSETS
Current Assets:
Cash and cash equivalents	$	300		$	3,015
Accounts receivable, net		211			530
Prepaid expenses and other assets		427			1,877
Total current assets		938			5,422
Noncurrent Assets:
Property and equipment:
Equipment		2,886			2,865
Capitalized software development		2,196			1,380
Furniture and fixtures		43			43
Leasehold improvements		78			78
Property and equipment, gross		5,203			4,366
Accumulated depreciation and amortization		(2,674	)		(2,208	)
Property and equipment, net		2,529			2,158
Finance leases, right-of-use assets, net		715			1,048
Operating leases, right-of-use assets, net		348			504
Other assets		147			143
Total noncurrent assets		3,739			3,853
TOTAL ASSETS	$	4,677		$	9,275

LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current Liabilities:
Accounts payable, trade	$	1,798		$	1,273
Accrued expenses		212			446
Finance lease liabilities, current portion		618			667
Operating lease liabilities, current portion		184			294
Notes payable		10,894			10,114
Deferred revenue		1,121			455
Total current liabilities		14,827			13,249

Noncurrent Liabilities:
Finance lease liabilities, noncurrent portion		4			10
Operating lease liabilities, noncurrent portion		167			231
Total noncurrent liabilities		171			241

Commitments and Contingencies – (See Note 5)		–			–

Stockholders’ Deficit:
Preferred stock, $0.01 par value: Authorized shares – 5,000 Issued shares – 0 in 2023 and 2022		–			–
Common stock, $0.01 par value: Authorized shares – 80,000; Issued shares – 22,442 in 2023 and 21,198 in 2022; Outstanding shares – 22,432 in 2023 and 21,188 in 2022		224			212
Common stock held in treasury, at cost – 10 shares		(362	)		(362	)
Additional paid-in capital		94,049			92,304
Accumulated deficit		(104,189	)		(96,326	)
Accumulated other comprehensive loss		(43	)		(43	)
Total stockholders’ deficit		(10,321	)		(4,215	)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT	$	4,677		$	9,275

The accompanying notes are an integral part of these condensed consolidated financial statements.

INTRUSION INC. AND SUBSIDIARIES
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share amounts)


	Three Months Ended						Six Months Ended
	June 30, 2023			June 30, 2022			June 30, 2023			June 30, 2022
Revenue	$	1,468		$	2,058		$	2,777		$	3,893
Cost of revenue		330			916			643			1,819

Gross profit		1,138			1,142			2,134			2,074

Operating expenses:
Sales and marketing		1,423			1,568			3,161			2,774
Research and development		1,451			1,486			3,247			3,136
General and administrative		1,185			2,049			2,691			4,109

Operating loss		(2,921	)		(3,961	)		(6,965	)		(7,945	)

Interest and other income		–			1			41			2
Interest expense		(208	)		(525	)		(939	)		(596	)
Gain on lease termination		–			420			–			420

Net loss	$	(3,129	)	$	(4,065	)	$	(7,863	)	$	(8,119	)

Net loss per share:
Basic	$	(0.15	)	$	(0.21	)	$	(0.37	)	$	(0.42	)
Diluted	$	(0.15	)	$	(0.21	)	$	(0.37	)	$	(0.42	)

Weighted average common shares outstanding:
Basic		21,383			19,372			21,225			19,238
Diluted		21,383			19,372			21,225			19,238

The accompanying notes are an integral part of these condensed consolidated financial statements.

INTRUSION INC. AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT

(In thousands)


	Common Stock				Treasury Stock					Accumulated Other Comprehensive Loss			Additional Paid-In-Capital			Accumulated Deficit			Total
	Dollars		Shares		Dollars			Shares		Dollars			Dollars			Dollars			Dollars
Balance, December 31, 2022	$	212		21,198	$	(362	)		10	$	(43	)	$	92,304		$	(96,326	)	$	(4,215	)
Stock-based compensation expense		–		–		–			–		–			94			–			94
Exercise of stock options		–		58		–			–		–			7			–			7
Public stock offering, net of fees		–		2		–			–		–			21			–			21
Withholdings related to stock-based compensation awards		–		–		–			–		–			(5	)		–			(5	)
Net loss		–		–		–			–		–			–			(4,734	)		(4,734	)
Balance, March 31, 2023	$	212		21,258	$	(362	)		10	$	(43	)	$	92,421		$	(101,060	)	$	(8,832	)
Stock-based compensation expense		–		–		–			–		–			331			–			331
Public stock offering, net of fees		10		970		–			–		–			1,299			–			1,309
Issuance of restricted stock, net of forfeitures		2		214		–			–		–			(2	)		–			–
Net loss		–		–		–			–		–			–			(3,129	)		(3,129	)
Balance, June 30, 2023	$	224		22,442	$	(362	)		10	$	(43	)	$	94,049		$	(104,189	)	$	(10,321	)

	Common Stock				Treasury Stock					Accumulated Other Comprehensive Loss			Additional Paid-In-Capital			Accumulated Deficit			Total
	Dollars		Shares		Dollars			Shares		Dollars			Dollars			Dollars			Dollars
Balance, December 31, 2021	$	191		19,135	$	(362	)		10	$	(43	)	$	84,230		$	(80,097	)	$	3,919
Public stock offering, net of fees		3		248		–			–		–			946			–			949
Stock-based compensation expense		–		–		–			–		–			427			–			427
Exercise of stock options		1		91		–			–		–			60			–			61
Net loss		–		–		–			–		–			–			(4,054	)		(4,054	)
Balance, March 31, 2022	$	195		19,474	$	(362	)		10	$	(43	)	$	85,663		$	(84,151	)	$	1,302
Stock-based compensation expense		–		–		–			–		–			450			–			450
Public stock offering, net of fees		1		84		–			–		–			254			–			255
Partial extinguishment of operating lease with common stock		–		75		–			–		–			200			–			200
Issuance of restricted stock, net of forfeitures		1		106		–			–		–			(1	)		–			–
Exercise of stock options		–		6		–			–					4			–			4
Net loss		–		–		–			–		–			–			(4,065	)		(4,065	)
Balance, June 30, 2022	$	197		19,745	$	(362	)		10	$	(43	)	$	86,570		$	(88,216	)	$	(1,854	)

The accompanying notes are an integral part of these condensed consolidated financial statements.

INTRUSION INC. AND SUBSIDIARIES
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)


	Six Months Ended
	June 30, 2023			June 30, 2022
Operating Activities:
Net loss	$	(7,863	)	$	(8,119	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization		798			616
Bad debt expense		48			–
Stock-based compensation		425			876
Non-cash lease costs		156			150
Amortization of debt issuance costs		555			133
Non-cash interest and interest accretion up to the redemption common stock settlement amount		225			306
Gain on lease termination		–			(420	)
Changes in operating assets and liabilities:
Accounts receivable		271			(255	)
Prepaid expenses and other assets		1,446			(425	)
Accounts payable and accrued expenses		172			141
Operating lease liabilities		(174	)		(882	)
Deferred revenue		666			754
Net cash used in operating activities		(3,275	)		(7,125	)

Investing Activities:
Capitalization of software development		(692	)		(350	)
Purchases of property and equipment		(25	)		(126	)
Net cash used in investing activities		(717	)		(476	)

Financing Activities:
Proceeds from notes payable		–			10,000
Payment on notes payable issuance costs		–			(710	)
Proceeds from stock options exercised		7			66
Proceeds from public stock offering net of fees		1,330			1,204
Withholdings related to stock-based compensation awards		(5	)		–
Reduction of finance lease liability		(55	)		(41	)
Net cash provided by financing activities		1,277			10,519

Net (decrease) increase in cash and cash equivalents		(2,715	)		2,918
Cash and cash equivalents at beginning of period		3,015			4,100
Cash and cash equivalents at end of period	$	300		$	7,018

SUPPLEMENTAL DISCLOSURE OF CASH FLOW ACTIVITIES:
Cash paid for interest	$	159		$	–

SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Common stock issued for lease termination	$	–		$	200
Equipment purchases and capitalized software included in accounts payable	$	119		$	–

The accompanying notes are an integral part of these condensed consolidated financial statements.

INTRUSION INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

1. Description of Business

Intrusion, Inc. (together with its consolidated subsidiaries, the “Company”, “Intrusion”, “Intrusion Inc.”, “we”, “us”, “our”, or similar terms) was organized in Texas in September 1983 and reincorporated in Delaware in October 1995. Our principal executive offices are located at 101 East Park Boulevard, Suite 1200, Plano, Texas 75074, and our telephone number is (972) 234-6400. Our website URL is www.intrusion.com.

The Company develops, sells, and supports products that protect any-sized company or government organization by fusing advanced threat intelligence with real-time mitigation to kill cyberattacks as they occur – including Zero-Days. The Company markets and distributes the Company’s solutions through value-added resellers, managed service providers and a direct sales force. The Company’s end-user customers include U.S. federal government entities, state and local government entities, and companies ranging in size from mid-market to large enterprises.

TraceCop (“TraceCop™”) and Savant (“Savant™”) are registered trademarks of Intrusion Inc. The Company has applied for trademark protection for the Company’s new INTRUSION Shield cybersecurity solution.

2. Basis of Presentation

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with Generally Accepted Accounting Principles in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Item 10-01 of Regulation S-X. Accordingly, they do not include all the information and disclosures required by GAAP for complete financial statements. All adjustments that, in the opinion of management, are necessary for a fair presentation of the results of operations for the interim periods have been made and are of a recurring nature unless otherwise disclosed herein. The results of operations for such interim periods are not necessarily indicative of results of operations for a full year. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and accompanying notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, filed with the U.S. Securities and Exchange Commission (the “SEC”) on March 31, 2023. All significant intercompany balances and transactions have been eliminated in consolidation.

The Company calculates the fair value of its assets and liabilities which qualify as financial instruments and includes this additional information in the notes to the condensed consolidated financial statements when the fair value is different from the carrying value of these financial instruments. The estimated fair value of accounts receivable, accounts payable and accrued expenses approximate their carrying amounts due to the relatively short maturity of these instruments. Notes payable and financing and operating leases approximate fair value as they bear market rates of interest. None of these instruments are held for trading purposes.

Going Concern

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As of June 30, 2023, the Company had cash and cash equivalents of $0.3 million and a working capital deficit of $13.9 million. In addition, the Company has incurred net operating losses during the last three years. The Company’s principal sources of cash for funding operations in 2022 was through the issuance of the two Streeterville notes which contributed $9.3 million, net of issuance costs and $6.4 million from the sale and issuance of common stock and warrants. The Streeterville notes discussed in Note 4 had original maturities of September 10, 2023, and December 29, 2023. On August 2, 2023, the notes were amended to extend the maturities by 12 months for each note. These conditions raise substantial doubt about the ability of the Company to continue as a going concern. Management plans to fund the operations of the Company through additional debt or equity financing. If the Company is not able to obtain additional debt or equity financing, the Company may be unable to implement the Company’s business plan, fund its liquidity needs or even continue its operations. The financial statements do not include any adjustments relating to the recoverability and classification of assets and liabilities that may be necessary if the Company is unable to continue as a going concern.

The audit opinion that accompanied the Company’s financial statements as of and for the year ended December 31, 2022, was qualified in that the Company’s auditors expressed substantial doubt about the Company’s ability to continue as a going concern.

3. Right-of-use Asset and Leasing Liabilities

The Company has operating and finance leases where it records the right-of-use assets and a related lease liability as required under ASC 842. The lease liabilities are determined by the net present value of total lease payments and amortized over the life of the lease. All obligations under the Company’s lease agreements are designed to terminate with the last scheduled payment. The Company’s leases are for the following types of assets:

Computer hardware and copy machines- The Company’s finance lease right-of-use assets consist of computer hardware and copy machines. These leases have a three-year life and are in various stages of completion.

Office space - The Company’s operating lease right-of-use assets include its rental agreements for its offices in Plano, TX, and a data service center in Allen, TX. The Plano offices operating lease expires this year. The data service center operating lease liability has a life of two years and four months as of June 30, 2023.

In accordance with ASC 842, the Company has elected practical expedients to combine lease and non-lease components, which consist principally of common area maintenance charges, for all classes of underlying assets and to exclude leases with an initial term of 12 months or less.

As the implicit rate is not readily determinable for the Company's lease agreements, the Company uses an estimated incremental borrowing rate to determine the initial present value of lease payments. This discount rate for the lease approximates the federal reserve’s prime rate.

For the three and six months ended June 30, 2023, the Company had $0.1 and $0.2 million respectively, in lease payments related to operating leases. For the three and six months ended June 30, 2023, the Company had $41 and $55 thousand respectively, in lease payments related to financing leases.

Schedule of Items Appearing on the Condensed Consolidated Statement of Operations (in thousands):

Lease cost table
	Three Months Ended				Six Months Ended
	June 30, 2023		June 30, 2022		June 30, 2023		June 30, 2022
Operating expense:
Amortization expense – Finance ROU	$	167	$	166	$	333	$	332
Lease expense – Operating ROU	$	79	$	91	$	156	$	186
Other expense:
Interest expense – Finance ROU	$	5	$	15	$	11	$	22

Future minimum lease obligations consisted of the following as of June 30, 2023 (in thousands):

Future minimum lease obligations
	Operating			Finance
Period ending December 31,	ROU Leases			ROU Leases			Total
2023		127			615			742
2024		123			8			131
2025		115			3			118
	$	365		$	626		$	991
Less Interest*		(14	)		(4	)
	$	351		$	622

*	Interest is imputed for operating ROU leases and classified as lease expense and is included in operating expenses in the accompanying Condensed Consolidated Statement of Operations.

4. Notes Payable

On March 10, 2022, Intrusion Inc. entered into a security purchase agreement (the “SPA”) with Streeterville Capital, LLC (“Streeterville”) whereby the Company issued two separate promissory notes of $5.4 million each, with an initial interest rate of 7%, subject to some increases in the case of among other things, an event of default. On March 10, 2022, the Company received $4.6 million in net funds from the first tranche (Note 1) pursuant to a promissory note executed contemporaneously with the execution of the loan agreement. On June 29, 2022, the Company received an additional $4.7 million in net funds from the second tranche (Note 2) pursuant to a promissory note. Each note had an 18-month maturity, may be prepaid subject to varying prepayment premiums, and may be redeemed at any time after six months into the term of such note in amounts up to $0.5 million per calendar month upon the noteholder’s election. On January 11, 2023, the Company amended the promissory notes issued pursuant to the unsecured loan agreement with Streeterville whereby the noteholder agreed to waive their redemption rights through March 31, 2023, in exchange for a fee equal to 3.75% of the outstanding principal balance which increased the outstanding indebtedness due at maturity with Streeterville and increased the associated debt issuance costs recorded on the Condensed Consolidated Balance Sheets by $0.4 million. On August 2, 2023, the Company entered into a Forbearance Agreement with Streeterville which was subsequently amended on August 7, 2023. The Forbearance Agreement and amendment extend the maturity dates for each Note by 12 months. In addition, Streeterville agreed to waive their right to redeem any portion of either Note for 180 days from the date on which the Company closes on a fully marketed public offering for aggregate proceeds, net of fees, of not less than $5,000,000, so long as the Qualified IPO occurs on or before October 1, 2023 (the “Standstill”). If a Qualified IPO does not occur by October 1, 2023, the Standstill shall not take effect. Upon the expiration of the Standstill, redemption obligations under the notes would resume, in addition to weekly cash payments to Streeterville in the amount of $50,000 due in the aggregate under the notes via ACH withdrawal. In consideration of the standstill and the extension of the maturity dates, the Company entered into a Security Agreement with Streeterville, dated August 2, 2023 (the “Security Agreement”), under which Streeterville was granted a first-position security interest in all assets of the Company.

During the three and six months ended and after June 30, 2023, no redemptions have been made to date. The Company has the option, in its sole discretion, to satisfy any redemption demands in cash or shares of its common stock that will be issued in an amount equal to the dollar amount of the redemption demand divided by the number that represents 85% of the average of the two lowest daily volume weighted average prices of common stock over a fifteen-day trailing period. This option to settle in shares at a 15% discount is deemed a beneficial conversion feature (“BCF”). Any remaining indebtedness at maturity is payable in cash.

The loan agreement and accompanying notes are subject to standard and customary events of default, including, without limitation, the Company’s continued listing on the Nasdaq or New York Stock Exchange. While the notes remain outstanding, the Company will be subject to certain conditions and restrictions, including, without limitation the following: the noteholder’s right to consent to any future variable rate transactions (excluding at-the market “ATMs”, equity offerings, or private placements without market adjustable features) and any debt (excluding bank loans, lines of credit, mortgagees, leases, or asset backed loans); the noteholder’s right to participate in any debt or equity financings, excluding (ATMs, loans, lines of credit, mortgagees, leases, or asset backed loans); a prohibition on the Company’s ability to extend or enter into any agreement restricting our ability to issue common stock under the notes; as well as a prohibition on our ability to permit any other lender to participate alongside the noteholder via any debt financing structures.

The Company evaluated both the Note 1 and Note 2 in accordance with ASC 480 “Distinguishing Liabilities from Equity” because the promissory note (1) embodies an unconditional obligation, (2) may require the Company to settle the optional redemption obligation by issuing a variable number of its common shares, and (3) is based solely on a fixed monetary amount known at inception.

The lender does not benefit if the fair value of the Company’s common stock increases and does not bear the risk that the fair value of the Company’s common stock might decrease. In accordance with ASC 480, the promissory notes have been recorded as a liability and the Company is recording interest expense over the term of the promissory note, using the interest method from ASC 835-30, to accrete the carrying amount of the promissory note up to the redemption common stock settlement amount.

The Company has recorded debt issue costs totaling $1.8 million associated with the issuance and amendment of the notes which are being amortized over their respective terms. As of June 30, 2023, the balance of unamortized debt issuance costs for both notes were $0.4 million.

For the three and six months ended June 30, 2023, the Company recorded $0.2 and $0.8 million respectively, of debt issuance costs and interest expense in the accompanying Condensed Consolidated Statement of Operations. The interest recorded associated with the unsecured promissory note increases the associated notes payable on the accompanying Condensed Consolidated Balance Sheet. As a result of the Forbearance Agreement and subsequent amendment discussed above, the balance of the notes payable mature in September 2024 and December 2024. The effective interest rate of the notes payable including amortization of the debt issuance costs and accretion of BCF is 14.8%.

5. Commitments and Contingencies

The Company is periodically involved in various litigation claims asserted in the normal course of its business. The Company believes these actions are routine and incidental to the business. While the outcome of these actions cannot be predicted with certainty, the Company does not believe that any will have a material adverse impact on the Company’s business.

Class Action Litigation

On April 16, 2021, a class action lawsuit was filed in the United States District Court, Eastern District of Texas, Sherman Division, captioned Celeste v. Intrusion Inc. et al., Case No. 4:21-cv-00307 (E.D. Tex.) against the Company, the Company’s now-former chief financial officer, and now-former chief executive officer alleging, among other things, that the defendants made false and/or misleading statements or omissions about the Company’s business, operations, and prospects in violation of Section 10(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Rule 10b-5 promulgated thereunder, as well as Section 20(a) of the Exchange Act. The Celeste lawsuit claimed compensatory damages and legal fees.

On May 14, 2021, a related class action lawsuit was filed in the United States District Court, Eastern District of Texas, Sherman Division, captioned Neely v. Intrusion Inc., et al., Case No. 4:12-cv-00374 (E.D. Tex.) against the Company, the Company’s now-former chief financial officer, and now-former chief executive officer. The Neely lawsuit alleged the same violations under the federal securities laws as those alleged in the Celeste lawsuit. The Neely lawsuit also sought compensatory damages and legal fees.

On November 23, 2021, the Court consolidated the Celeste and Neely actions, and appointed a lead plaintiff and lead plaintiff’s counsel. The lead plaintiff filed his amended complaint on February 7, 2022. The amended complaint named the following additional parties as named defendants: Mr. Michael Paxton, a former director and executive officer; Mr. Gary Davis, a former officer; Mr. Joe Head, the current chief technology officer, and a former director; and Mr. James Gero, a current director and chair of the compensation committee.

The parties to the consolidated action held a mediation on April 5, 2022, at the conclusion of which the parties executed a settlement term sheet setting forth the material terms associated with the resolution of the action, subject to the preparation of formal documents and a plan of distribution approved by the Court. The settlement agreement was subject to certain terms and conditions and received final approval by the Court on December 16, 2022. At that time, a final judgment was entered dismissing the case, with the Court retaining jurisdiction over the action for purposes of enforcing the terms of the class settlement agreement. The $3.3 million settlement was paid by the Company’s insurance provider under its insurance policy as the Company’s retention had previously been exhausted.

The lead plaintiff in the class action filed a motion for distribution of settlement funds on February 21, 2023. The Court approved the parties’ class action settlement and plan of allocation on March 22, 2023, and cancelled the previously rescheduled March 31, 2023, hearing on the motion for distribution, all remaining matters in the class action then-pending having been fully and finally adjudicated.

Securities Investigation

On August 8, 2021, the Company received a notification from the Securities and Exchange Commission, Division of Enforcement, that it was investigating captioned In the Matter of Intrusion Inc. and requesting the Company produce certain documents and information. On November 9, 2021, the Securities and Exchange Commission served a subpoena to the Company in connection with this investigation which formally requested substantially similar information as in the prior request. The Company is continuing to comply with the requests and is cooperating in the investigation. The Company can offer no assurances as to the outcome of this investigation or its potential effect on the Company or its results of operations.

Stockholder Derivative Claim

On June 3, 2022, a verified stockholder derivative complaint was filed in U.S. District Court, District of Delaware by plaintiff Nathan Prawitt (the “Plaintiff Stockholder”) on behalf of Intrusion against certain of the Company’s current and former officers and directors (the “Defendants”). Plaintiff alleges that Defendants through various actions breached their fiduciary duties, wasted corporate assets, and unjustly enriched Defendants by (a) incurring costs and expenses in connection with the ongoing SEC investigation, (b) incurring costs and expenses to defend the Company with respect to the consolidated class action, (c) settling class-wide liability with respect to the consolidated class action, as well as ancillary claims regarding sales of the Company’s common stock by certain of the Defendants. The Plaintiff is seeking remedial actions including improvements in the Company’s corporate governance and internal control policies and reimbursement of legal costs. While the Company is not a named defendant, but a nominal plaintiff in the stockholder derivative claim, the Company will be providing the financial and other assistance for each of the Defendants that the Company is obligated to provide under the Company’s Articles of Incorporation, the Company’s Bylaws, as well as individual indemnifications agreements that are in effect between, the Company and each of the Defendants.

In addition to these legal proceedings, the Company is subject to various other claims that may arise in the ordinary course of business. The Company does not believe that any claims exist where the outcome of such matters would have a material adverse effect on the Company’s condensed consolidated financial position, operating results, or cash flows. However, there can be no assurance such legal proceedings will not have a material impact on the Company’s future results.

6. Common Stock

ATM Offering

In August of 2021, the Company engaged B. Riley Securities, Inc. to act as sales agent under the Company’s at-the-market program, which allows us to potentially sell up to $50.0 million of its common stock using a shelf registration statement on Form S-3 filed on August 5, 2021. On March 31, 2023, the date we filed our Annual Report on Form 10-K for the fiscal year ended December 31, 2022, the Company became subject to the offering limits in General Instruction I.B.6 of Form S-3. As a result, the Company filed a prospectus supplement to the prospectus relating to the registration of offerings under the program that reduced the amount the Company may sell to aggregate proceeds of up to $15 million. For the six months ended June 30, 2023, the Company has received proceeds of approximately $1.3 million net of fees from the sale of common stock pursuant to the program. As of June 30, 2023, the Company has received proceeds of approximately $8.9 million net of fees from the sales of 2.8 million shares of common stock since the inception of the program.

Registered Direct Offering

On September 12, 2022, the Company entered in a Securities Purchase Agreement (the “Purchase Agreement”) with certain purchasers to issue and sell to the purchasers an aggregate of 1,378,677 shares of the Company’s common stock (the “Shares”) each of which was coupled with a warrant to purchase one share of common stock (the “Warrants”) at an aggregate offering price of $4.29 per share and warrant, such offering is hereinafter referred to as its “registered direct offering”. Each warrant has an exercise price of $5.22 per share of common stock, subject to adjustment for stock splits, reverse stock splits, stock dividends and similar transactions and is exercisable from the date of its issuance through September 14, 2027. The Company delivered 939,284 Shares and Warrants on or about September 14, 2022. After September 30, 2022, the company issued an additional 273,309 Shares and related Warrants as a result of delayed closings. On November 10, 2022, the Company, reached an agreement with the sole remaining delayed basis investor in the registered direct offering to reduce the purchaser’s subscription by $0.7 million and, accordingly, reduce the Company’s obligation to issue securities. Following the final closing, the Company had received from its registered direct offering total aggregate proceeds of $5.2 million in exchange for the issuance of an aggregate of 1,212,593 shares of common stock and warrants to purchase 1,212,593 shares of common stock.

7. Stock-Based Compensation

The Company accounts for stock-based compensation in accordance with ASC 718, Compensation – Stock Compensation, which requires that compensation related to all stock-based awards be recognized in the condensed consolidated financial statements. Stock-based compensation cost is valued at fair value at the date of grant, and the grant date fair value is recognized as expense over each award’s requisite service period with a corresponding increase to equity or liability based on the terms of each award and the appropriate accounting treatment under ASC 718.

The Company has three stock-based compensation plans as of June 30, 2023, and 2022. These plans include the 2021 Omnibus Incentive Plan, the 2015 Stock Incentive Plan and the 2005 Stock Incentive Plan. These plans are discussed in detail in our Annual Report Form 10-K for the year ended December 31, 2022, filed with the SEC.

The Company grants stock from both the 2021 Omnibus Incentive Plan and the 2015 Stock Incentive Plan. These plans provide a means through which the Company may attract and retain key personnel and to provide a means whereby directors, officers, employees, consultants and advisors of the Company can acquire and maintain an equity interest in the Company, or be paid incentive compensation, including incentive compensation measured by reference to the value of common stock, thereby strengthening their commitment to the welfare of the Company and aligning their interests with those of the Company’s stockholders.

During the six months ended June 30, 2023, the Company granted 213.7 thousand restricted stock awards “RSAs” compared to 131.6 thousand similar awards in the same period in 2022. The Company recognized compensation expense related to RSAs of $0.1 and $0.2 million, for the three and six month ended June 30, 2023, compared to $0.1 and $0.3 million for the three and six months ended June 30, 2022. As of June 30, 2023, the total unrecognized compensation cost related to non-vested RSAs not yet recognized in the condensed consolidated statement of operations totaled $0.3 million.

During the six months ended June 30, 2023, the Company granted 626.4 thousand stock options compared to 167.5 thousand similar awards in the same period in 2022. The Company recognized compensation expenses related to stock options of $0.2 and $0.2 million, for the three and six month ended June 30, 2023, compared to $0.4 and $0.6 million for the three and six months ended June 30, 2022. As of June 30, 2023, the total unrecognized compensation cost related to non-vested options not yet recognized in the condensed consolidated statement of operations totaled $0.6 million.

The following table summarizes the activities for the Company’s stock options for the six months ended June 30, 2023:

Schedule of stock option activities
	June 30, 2023
	Number of Options			Weighted Average
	(In thousands)			Exercise Price
Outstanding at beginning of year		668		$	5.22
Granted		626			1.25
Exercised		(72	)		0.48
Forfeited		(167	)		4.37
Expired		(42	)		8.19
Outstanding on June 30, 2023		1,013		$	3.12
Options exercisable on June 30, 2023		368		$	4.61

Valuation Assumptions

The fair values of employee option awards were estimated at the date of grant using a Black-Scholes option-pricing model with the following assumptions:


	For Three Months Ended June 30, 2023		For Three Months Ended June 30, 2022		For Six Months Ended June 30, 2023		For Six Months Ended June 30, 2022
Weighted average grant date fair value	$	1.09	$	–	$	1.08	$	3.34
Weighted average assumptions used:
Expected dividend yield		0.0%		0.0%		0.0%		0.0%
Risk-free interest rate		3.53%		0.0%		3.68%		0.88%
Expected volatility		103.2%		0.0%		114.1%		133.0%
Expected life (in years)		6.4		–		6.4		6.6

Expected volatility is based on historical volatility and in part on implied volatility. The expected term considers the contractual term of the option as well as historical exercise and forfeiture behavior. The risk-free interest rate is based on the rates in effect on the grant date for United States (“U.S.”) Treasury instruments with maturities matching the relevant expected term of the award.

8. Revenue Recognition

The Company generally recognizes product revenue upon shipment or after meeting certain performance obligations. These products can include hardware, software subscriptions and consulting services. The Company also offers software on a subscription basis subject to software as a service (“SAAS”). Warranty costs and sales returns have not been material.

The Company recognizes sales of its data sets in accordance with FASB ASC Topic 606 whereby revenue from contracts with customers are recognized once the criteria under the five steps below have been met:

	i)	identification of the contract with a customer;

	ii)	identification of the performance obligations in the contract;

	iii)	determination of the transaction price;

	iv)	allocation of the transaction price to each separate performance obligations; and

	v)	recognition of revenue upon satisfaction of a performance obligation.

Consulting services generally include reporting and are typically done monthly, and revenue is matched accordingly. Product sales may include maintenance and customer support allocated revenue in an arrangement using estimated selling prices of the delivered goods and services based on a selling price hierarchy using the relative selling price method. All product offering and service offering market values are readily determined based on current and prior stand-alone sales. The Company defers and recognizes maintenance, updates, and support revenue over the term of the contract period, which is generally one year.

Normal payment terms offered to customers, distributors and resellers are net 30 days domestically. The Company does not offer payment terms that extend beyond one year and rarely does it extend payment terms beyond its normal terms. If certain customers do not meet the Company’s credit standards, the Company typically requires payment in advance to limit its credit exposure.

Shipping and handling costs are billed to the customer and included in revenue. Shipping and handling expenses are included in the cost of revenue. The Company has elected to account for shipping and handling costs as fulfillment costs after the customer obtains control of the goods.

With the Company’s newest product, INTRUSION Shield, Intrusion began offering software on a subscription basis. INTRUSION Shield is a hosted arrangement subject to software as a service (“SaaS”) guidance under ASC 606. SaaS arrangements are accounted for as service obligations, not arrangements that transfer a license of intellectual property.

The Company utilizes the five-step process, mentioned above, per FASB ASC Topic 606 to recognize sales and will follow that directive, also, to define revenue items as individual and distinct. INTRUSION Shield services provided to the Company’s customers for a fixed monthly subscription fee include:

	·	Access to Intrusion’s proprietary software and database to detect and prevent unauthorized access to its clients’ information networks;

	·	Use of all software, associated media, printed materials, data, files, online documentation, and any equipment that Intrusion provides for customers to access the INTRUSION Shield; and

	·	Tech support, post contract customer support (PCS) includes daily program releases or corrections provided by Intrusion without additional charge.

INTRUSION Shield

Contracts provide for no other services, and our customers have no rebates or return rights, nor are any such rights anticipated to be offered as part of this service.

The Company satisfies its performance obligation when the INTRUSION Shield solution is available to detect and prevent unauthorized access to a client’s information networks. Revenue should be recognized monthly over the term of the contract. The Company’s standard initial contract terms automatically renew unless notice is given 30 days before renewal. Upfront payment of fees is deferred and amortized into income over the period covered by the contract.

The Company’s accounts receivable represents unconditional contract billings for sales per contracts with customers and are classified as current assets. As of June 30, 2023, and December 31, 2022, the Company had accounts receivable balances of $0.2 and $0.5 million, respectively. The Company had an allowance for doubtful accounts on June 30, 2023, of $42 thousand. There was no allowance for doubtful accounts on December 31, 2022.

We had no material contract assets as of June 30, 2023, and December 31, 2022.

Contract liabilities consist of cash payments in advance of the Company satisfying performance obligations and recognizing revenue. The Company currently classifies contract liabilities as deferred revenue.

The following table presents changes in the Company’s contract liability during the six months ended June 30, 2023, and the year ended December 31, 2022 (in thousands):

Schedule of contract liability
	June 30, 2023			December 31, 2022
Balance at beginning of period	$	455		$	560
Additions		2,047			1,877
Revenue recognized		(1,381	)		(1,982	)
Balance at end of period	$	1,121		$	455

9. Capitalized Software Development

The Company capitalizes internally developed software using the Agile software development methodology which allows the Company to accurately track, and record costs associated with new software development and enhancements.

Pursuant to ASC Topic 350-40 Internal Use Software Accounting Capitalization, certain development costs related to the Company’s products during the application development stage are capitalized as part of property and equipment. Costs incurred in the preliminary stages of development are expensed as incurred. The preliminary stage includes such activities as conceptual formulation of alternatives, evaluation of alternatives, determination of existence of needed technology, and the final selection of alternatives. Once the application development stage is reached, internal and external costs are capitalized until the software is complete and ready for its intended use. Capitalized internal use software is amortized on a straight-line basis over its estimated useful life, which is generally three years.

10. Net Loss Per Share

The Company reports two separate net loss per share numbers, basic and diluted. Basic net loss attributable to common stockholders per share is computed by dividing net loss attributable to common stockholders for the period by the weighted average number of common shares outstanding for the period. Diluted net loss attributable to common stockholders per share is computed by dividing the net loss attributable to common stockholders for the period by the weighted average number of common shares and dilutive common stock equivalents outstanding for the period. The common stock equivalents include all common stock issuable upon exercise of outstanding warrants, options and vesting of restricted stock awards. The aggregate number of common stock equivalents excluded from the diluted loss per share calculation for the three months ended June 30, 2023, and 2022 totaled 2,497 and 611 thousand shares, respectively. The aggregate number of common stock equivalents excluded from the diluted loss per share calculation for the six months ended June 30, 2023, and 2022 totaled 2,278 and 629 thousand shares, respectively. Since the Company is in a net loss position for the three and six months ended June 30, 2023, and 2022, basic and dilutive net loss per share is the same.

11. Correction of Immaterial Error

During the year ending December 31, 2022, management identified and corrected certain immaterial errors in the Company’s historical financial statements associated with the cost of revenues provided by a subcontractor. The errors understated the cost of revenue and overstated the sales and marketing operating expenses by equal amounts in the Condensed Consolidated Statements of Operations. The error had no impact on operating losses, net losses, and net loss per share nor any other financial statement amount. Further these errors had no impact on the consolidated balance sheets, statements of changes in stockholders’ equity (deficit), and statement of cash flows. These corrections do not affect any of the metrics used to calculate and evaluate management’s compensation and had no impact on bonuses, commissions, stock-based compensation, or any other employee renumeration. Historical amounts have been corrected and are presented on a comparable basis.

The below tables present (in thousands) the effect of the correction for the following periods:

Schedule of effect of the correction
	Three Months Ended June 30, 2022
	As Reported			Adjustments			As Corrected
Revenue	$	2,058		$	–		$	2,058
Cost of revenue		667			249			916

Gross profit		1,391			(249	)		1,142

Operating expenses
Sales and marketing		1,817			(249	)		1,568
Research and development		1,486			–			1,486
General and administrative		2,049			–			2,049

Operating loss	$	(3,961	)	$	–		$	(3,961	)


	Six Months Ended June 30, 2022
	As Reported			Adjustments			As Corrected
Revenue	$	3,893		$	–		$	3,893
Cost of revenue		1,321			498			1,819

Gross profit		2,572			(498	)		2,074

Operating expenses
Sales and marketing		3,272			(498	)		2,774
Research and development		3,136			–			3,136
General and administrative		4,109			–			4,109

Operating loss	$	(7,945	)	$	–		$	(7,945	)

12. Subsequent Event

On August 2, 2023, the Company entered into a Forbearance Agreement with Streeterville which was subsequently amended on August 7, 2023. The Forbearance Agreement and amendment extend the maturity dates for each Note by 12 months. In addition, Streeterville waived their right to redeem any portion of either Note for 180 days from the date on which the Company closes on a fully marketed public offering for aggregate proceeds, net of fees, of not less than $5,000,000, so long as the Qualified IPO occurs on or before October 1, 2023 (the “Standstill”). If a Qualified IPO does not occur by October 1, 2023, the Standstill shall not take effect. Upon the expiration of the Standstill, redemption obligations under the notes would resume, in addition to weekly cash payments to Streeterville in the amount of $50,000 due in the aggregate under the notes via ACH withdrawal. In consideration of the standstill and the extension of the maturity dates, the Company entered into a Security Agreement with Streeterville, dated August 2, 2023 (the “Security Agreement”), under which Streeterville was granted a first-position security interest in all assets of the Company.

On August 11, 2023, the Company filed a preliminary registration statement on Form S-1 under the Securities Act of 1933 to raise up to $8.5 million in gross proceeds, or $7.5 million net of fees, through issuance of common stock or a pre-funded warrant to purchase common stock and a warrant to purchase common stock.

Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward Looking Statements

This Quarterly Report on Form 10-Q, including, without limitation, the section entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), which statements involve substantial risks and uncertainties. All statements other than statements of historical facts contained in this Quarterly Report on Form 10-Q, including statements regarding our financial position; our ability to continue our business as a going concern; our business, sales, and marketing strategies and plans; our ability to successfully market, sell, and deliver our INTRUSION Shield commercial product and solutions to an expanding customer base; and our ability to secure additional financing; are forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” or “would” or the negative of these words or other similar terms or expressions. Forward-looking statements contained in this Quarterly Report on Form 10-Q include, but are not limited to, such statements.

You should not rely on forward-looking statements as predictions of future events. We have based the forward-looking statements contained in this Quarterly Report on Form 10-Q primarily on our current expectations and projections about future events and trends that we believe may affect our business, financial condition, and operating results. The outcome of the events described in these forward-looking statements is subject to risks, uncertainties, and other factors described in the section titled “Risk Factors” and elsewhere in this Quarterly Report on Form 10-Q and our most recent Annual Report on Form 10-K.

In addition, statements that “we believe” and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based on information available to us as of the date of this Quarterly Report on Form 10-Q. While we believe that such information provides a reasonable basis for these statements, that information may be limited or incomplete. Our statements do not indicate that we have conducted an exhaustive inquiry into, or review of, all relevant information. These statements are inherently uncertain, and investors are cautioned not to unduly rely on these statements.

The forward-looking statements made in this Quarterly Report on Form 10-Q relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statements made in this Quarterly Report on Form 10-Q to reflect events or circumstances after the date of this Quarterly Report on Form 10-Q or to reflect new information or the occurrence of unanticipated events, except as required by law.

Overview

Intrusion offers businesses of all sizes and industries products and services that leverage the Company’s exclusive threat intelligence database of over 8.5 billion IP addresses and domain names. After many years of gathering intelligence and providing our INTRUSION TraceCop and Savant solutions exclusively to government entities, we released our first commercial product in 2021, the INTRUSION Shield. INTRUSION Shield was designed to allow businesses to incorporate a Zero Trust, reputation-based security solution into their existing infrastructure to observe traffic flow and instantly block known malicious or unknown connections from both entering or exiting a network, making it an ideal solution for protecting from Zero-Day and ransomware attacks.

Much of 2022 was spent improving the INTRUSION Shield On-Premise performance and developing the Shield Cloud and End-Point solutions, both of which were released in September 2022. During the six months ended June 2023, our primary focus has been building out our sales reseller and channel platform and working with those partners to 1) increase our sales pipeline and 2) progress customer prospects, leads and opportunities through the sales lifecycle. Gaining traction with our Shield solutions has taken longer than initially anticipated. We feel that the progress made with our reseller and channel community along with refining our product messaging will help to shorten the sales cycle and grow revenues in future periods.

As discussed in more detail below on June 30, 2023, we had $0.3 million in cash. If we are not able to obtain additional debt or equity financing on terms and conditions acceptable to us, we may be unable to implement our business plan, fund our liquidity needs or even continue our operations.

Results of Operations

The following table sets forth, for the periods indicated, certain financial data as a percentage of net revenues. The period-to-period comparison of results is not necessarily indicative of future results.

	Three Months Ended				Six Months Ended
	June 30, 2023		June 30, 2022		June 30, 2023		June 30, 2022
Revenue		100.0%		100.0%		100.0%		100.0%

Cost of revenue		22.5%		44.5%		23.2%		46.7%

Gross profit		77.5%		55.5%		76.8%		53.3%

Operating expenses:
Sales and marketing		96.9%		76.2%		113.8%		71.3%
Research and development		98.8%		72.2%		116.9%		80.6%
General and administrative		80.7%		99.6%		96.9%		105.5%

Operating loss		-199.0%		-192.5%		-250.8%		-204.1%

Interest and other income		–		–		1.5%		0.1%
Interest expense		-14.2%		-25.5%		-33.8%		-15.3%
Gain on lease termination		–		20.4%		–		10.8%

Net loss		-213.1%		-197.5%		-283.1%		-208.5%

Revenues. Revenue for the three and six month periods ended June 30, 2023, was $1.5 and $2.8 million compared to $2.1 and $3.9 million for the same periods in 2022. Revenue from our consulting business was $1.1 and $2.1 million for the three and six month periods ended June 30, 2023, compared to $1.7 and $3.3 million for same periods in 2022. INTRUSION Shield revenues were $0.4 and $0.7 million for the three and six month periods ended June 30, 2023, compared to $0.4 and $0.6 million for the three and six month periods ended June 30, 2022.

Concentration of Revenues. For the three and six month periods ended and June 30, 2023, revenues from sales to various U.S. government entities totaled $0.7 and $1.3 million, or 46.7% and 47.5% of revenues compared to $1.4 and $2.7 million, or 65.7% and 68.8% of revenues, for the same periods in 2022. Although we expect our concentration of revenues to vary among customers in future periods depending upon the timing of certain sales, we anticipate that sales to government customers will continue to account for a significant portion of our revenues in future periods. Sales to the government present risks in addition to those involved in sales to commercial customers which could adversely affect our revenues, including, without limitation, potential disruption to appropriation and spending patterns and the government’s reservation of the right to cancel contracts and purchase orders for its convenience. Although we do not anticipate that any of our revenues from government customers will be renegotiated, any cancelled or renegotiated government orders could have a material adverse effect on our financial results. We had two commercial customers in the three and six months ended June 30, 2023 and 2022, that each contributed individually to more than 10% of our total revenue. Our similar product and service offerings are not viewed as individual segments, as its management analyzes the business as a whole and expenses are not allocated to each product offering.

Gross Profit. Gross profit was $1.1 and $2.1 million or 77.5% and 76.8% of revenues for the three and six month periods ended June 30, 2023, compared to $1.1 and $2.1 million or 55.5% and 53.3% of revenues for the three and six month periods ended June 30, 2022. The increased gross profit is largely due to the loss of the low margin government contract and a shift in product mix with Shield representing a greater percentage of sales.

Operating Expenses. Operating expenses for the three and six months ended June 30, 2023, totaled $4.1 and $9.1 million, a decrease of 19.6% and 9.0% when compared to $5.1 and $10.0 million for the same periods in 2022. The period over period change was most notably due to reduced legal expense associated with the various litigation matters that arose in 2021, reduced consulting expense and lower stock-based compensation.

In late March 2023, we implemented cost reduction measures that will approximate $1.5 million per quarter on a go-forward basis. There was no impact on operating expenses in the March quarter resulting from these reductions. In the June quarter we realized $1.2 million in cost savings excluding the impact of non-cash stock-based compensation. The reductions included the voluntary reduction in compensation for certain of our executive officers for a 6-month period, elimination of 16 full-time positions (“RIF”) and decreased use of contractors. As a form of retention incentive for employees not impacted by the RIF and in exchange for the voluntary reduction in compensation, we issued 553 thousand options for the purchase of shares of common stock.

Sales and Marketing. Sales and marketing expenses were $1.4 and $3.2 million for the three and six month periods ended June 30, 2023, compared to $1.6 and $2.8 million for the three and six month periods in 2022. Certain discretionary marketing spend inclusive of participation in trade shows, utilization of third-party contractors for content and product messaging and travel, are likely to vary over time based on savings initiatives that may be necessary.

Research and Development. For the three and six month periods ended June 30, 2023, research and development expenses were $1.5 and $3.2 million compared to $1.5 and $3.1 million for the three and six month period ended June 30, 2022. In the second quarter of 2022, we implemented the Agile methodology of software development to manage and track our development costs. As a result, we are able to accurately quantify and capture the cost associated with each stage of the development life cycle and, accordingly, are capitalizing costs incurred during the application development stage. For the three and six month periods ended June 30, 2023, we recorded $0.3 and $0.8 million of research and development costs to internal use software compared to $0.4 million for the period ended June 2022. The net increased spend for the six month period, including amounts capitalized, of $0.5 million related to costs to harden the design and user interface related to the Shield suite of products. Research and development costs may vary over time as we determine the frequency of new releases, improved functionality and enhancements needed to be competitive with our product offering.

General and Administrative. General and administrative expenses were $1.2 and $2.7 million for the three and six month periods ended June 30, 2023, compared to $2.0 and $4.1 million for the three and six month periods ended June 30, 2022. The decrease in general and administrative expenses is primarily due to a reduction in legal costs of $0.7 and $0.9 million for the three and six month periods associated with various litigation matters that arose in 2021 and reduced use of contractors in 2023 of $0.4 million.

Interest Expense. Our interest expense consists primarily of interest related to the Streeterville notes entered into in March and June of 2022 and related debt issuance cost amortization as well as interest expense from finance leases. Interest expense for the quarter ended June 30, 2023, decreased $0.3 million to $0.2 million. The decrease primarily relates to the reversal of interest recorded to accrete the value of the Streeterville notes to the stock-settled value for potential redemptions paid in stock as no redemption payments in cash or stock were made in the quarter. Interest expense for the six months ended June 30, 2023, totaled $0.9 million compared to $0.6 million for the six months ended June 30, 2022. The increase is due to the Streeterville notes not being outstanding for the full six-months in 2022. Interest expense will vary in the future based on our cash flow and borrowing needs.

Interest and Other Income. Interest and other income were negligible for the three and six month periods ended June 30, 2023, and 2022.

Gain on Extinguishment of Lease and Debt. For the three and six month periods ended June 30, 2022, we had a gain on extinguishment of lease of $0.4 million.

Liquidity and Capital Resources

As of August 11, 2023, we had $0.3 million of cash, which is not sufficient to cover our monthly operating needs. We need to raise additional funds in the near term to continue operations and comply with our financial obligations. We intend to obtain these funds through one or more offerings of debt or equity securities, including through registered direct offerings, private placements, and the use of our at-the-market program. We can provide no assurances that we will be able to obtain such financing on acceptable terms or at all and, in the case of equity or equity-linked financings, such financings will result in dilution to our stockholders.

Sources of Liquidity

As of June 30, 2023, we had cash and cash equivalents of $0.3 million, down from $3.0 million as of December 31, 2022, and a working capital deficit of ($13.9) million compared to ($7.8) million as of December 31, 2022. Our principal source of cash for funding operations and growth in 2022 were issuance of the two Streeterville notes which contributed $9.3 million, net of issuance costs, and $6.4 million from the sale and issuance of common stock and warrants. Our principal sources of cash for funding operations in 2023 has been $1.3 million net of fees received from our at-the-market program and through changes in working capital which includes receipt of the remaining ERC refund in the March quarter of $1.4 million.

2022 Notes Issuance

We entered into a SPA with Streeterville on March 10, 2022, pursuant to which Streeterville purchased two unsecured promissory notes with substantively identical terms. Streeterville purchased the first note on March 10, 2022, and the second note on June 29, 2022, each note with an aggregate principal amount of $5.4 million in exchange for $5.0 million less certain expenses. We received an aggregate of approximately $9.3 million, net of transaction expenses, in connection with these issuances.

The notes had original maturity dates in September and December 2023 and, as a result, are reflected as a current liability on our condensed consolidated balance sheets. Streeterville has the right to redeem up to $0.5 million of the outstanding balance of each note per month. Payments may be made by the Company, generally at the Company’s option, (a) in cash, (b) by paying the redemption amount in the form of shares of common stock or (c) a combination of cash and shares of common stock. If paid in common stock, the number of redemption shares to be issued is based on a 15% discount to market, as further defined in the note agreements. Through December 2022, Streeterville made three separate redemption requests totaling $1.5 million, which we satisfied cash. In January 2023, the note agreements were amended whereby Streeterville waived their right to redemptions through March 31, 2023, in exchange for a fee equal to 3.75% of the outstanding note balance. This fee was added to the outstanding principal balance to be paid at maturity. No redemptions have been made in 2023. As of June 30, 2023, our total outstanding amount payable to Streeterville which includes principal, accrued interest and fees associated with agreement modifications was $10.9 million.

On August 2, 2023, the Company entered into a Forbearance Agreement with Streeterville which was subsequently amended on August 7, 2023. The Forbearance Agreement and amendment extend the maturity dates for each Note by 12 months. In addition, Streeterville waived their right to redeem any potion of either Note for 180 from the date on which the Company closes on a fully marketed public offering for aggregate proceeds, net of fees, of not less than $5.0 million, so long as the qualified public offering occurs on or before October 1, 2023. If a Qualified IPO does not occur by October 1, 2023, the Standstill shall not take effect. Upon the expiration of the Standstill, redemption obligations under the notes would resume, in addition to weekly cash payments to Streeterville in the amount of $50,000 due in the aggregate under the notes via ACH withdrawal. In consideration of the stand still and the extension of the maturity dates, the Company entered into a Security Agreement with Streeterville, dated August 2, 2023, under which Streeterville was granted a first-position security interest in all assets of the Company. However, there can be no assurance that we will improve our liquidity position or our ability to make redemption or principal payments.

At-The-Market Program

In August of 2021, the Company engaged B. Riley Securities, Inc. to act as sales agent under the Company’s at-the-market program, which allowed us to potentially sell up to $50.0 million of its common stock using the shelf registration statement on Form S-3 filed on August 5, 2021. On March 31, 2023, the date we filed our Annual Report on Form 10-K for the fiscal year ended December 31, 2022, the registration became subject to the offering limits in General Instruction I.B.6 of Form S-3. As a result, we filed a prospectus supplement to the prospectus relating to the registration of offerings under the program that reduced the amount we may sell to aggregate proceeds of up to $15 million. For the six months ended June 30, 2023, we received $1.3 million, net of fees for sales of common stock were made pursuant to the program.

For so long as our public float is less than $75 million, we will be subject to the restrictions set forth in General Instruction I.B.6 to Form S-3, which limit our ability to conduct primary offerings under a Form S-3 registration statement, including with respect to issuances under our at-the-market program. Under such limitations, we may not sell, during any 12-month period, securities on Form S-3 having an aggregate market value of more than one-third of our public float. As of August 11, 2023, our public float calculated in accordance with General Instruction I.B.6 of Form S-3 was $21.4 million.

Condensed Consolidated Statements of Cash Flows

Our cash flows for the six months ended June 30, 2023, and 2022 (in thousands) were:

	Six Months Ended
	June 30, 2023			June 30, 2022
Net cash used in operating activities	$	(3,275	)	$	(7,125	)
Net cash used in investing activities		(717	)		(476	)
Net cash provided by financing activities		1,277			10,519
Change in cash and cash equivalents	$	(2,715	)	$	2,918

Operating Activities

Net cash used in operations for the six months ended June 30, 2023, was ($3.3) million due to a net loss of ($7.9) million, offset by 1) adjustments for non-cash items of $2.2 million which are mostly comprised of depreciation, stock-based compensation, and interest related to Streeterville notes and 2) changes in working capital of $2.4 million consisting principally of the cash receipt of amounts due relating to Employee Retention Credit and amounts received as prepayment for a one-year customer contract.

Net cash used in operations for the six months ended June 30, 2022, was ($7.1) million due primarily to a net loss of ($8.1) million partially offset by the following sources of cash and non-cash items: $1.7 million add back of non-cash expense comprised mostly of depreciation and stock-based compensation and ($0.7) million changes in working capital.

Investing Activities

For the six months ended June 30, 2023, net cash used in investing activities was ($0.7) million, which was principally the capitalization of internally developed software. Net cash used by investing activities, for the six months ended June 30, 2022, was ($0.5) million consisting of $0.4 million of capitalized internally developed software and $0.1 million for purchases of property and equipment.

Financing Activities

For six months ended June 30, 2023, net cash provided by financing activities was $1.3 million which consisted of proceeds from sales of common stock using our at-the-market program partially offset by finance lease payments. Cash provided by financing activities for the 2022 period totaled $10.5 million which was primarily the result of net proceeds from issuance of the Streeterville notes of $9.3 million and sales of stock using our at-the-market program of $1.2 million.

Critical Accounting Policies and Use of Estimates

Our condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles. The preparation of these condensed consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses, and related disclosures. We base our estimates on historical experience and on various other assumptions that we believe are reasonable under the circumstances. We evaluate our estimates and assumptions on an ongoing basis. Actual results may differ from these estimates. To the extent that there are material differences between these estimates and our actual results, our future financial statements will be affected.

We believe the critical accounting policies and estimates discussed under “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in our Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on March 31, 2023, reflect our more significant judgments and estimates used in the preparation of the condensed consolidated financial statements. There have been no other significant changes to our critical accounting policies and estimates as filed in such report.

Item 4. CONTROLS AND PROCEDURES

We maintain “disclosure controls and procedures,” as defined in Rule 13a-15(e) under the Exchange Act, that are designed to ensure that information required to be disclosed by us in reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating our disclosure controls and procedures, management recognized that disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable assurance of achieving the desired control objectives, and we must apply our reasonable judgment in evaluating the cost-benefit relationship of potential disclosure controls and procedures.

As of June 30, 2023, our management, including our principal executive officer and principal financial officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures and concluded that the disclosure controls and procedures were effective.

There have not been any changes in our internal control over financial reporting that occurred during the quarter ended June 30, 2023, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II – OTHER INFORMATION

Item 1. LEGAL PROCEEDINGS

Class Action Litigation

On April 16, 2021, a class action lawsuit was filed in the United States District Court, Eastern District of Texas, Sherman Division, captioned Celeste v. Intrusion Inc. et al., Case No. 4:21-cv-00307 (E.D. Tex.) against us, our now-former chief financial officer, and now-former chief executive officer alleging, among other things, that the defendants made false and/or misleading statements or omissions about our business, operations, and prospects in violation of Section 10(b) of the Securities Exchange Act of 1934, as amended, and Rule 10b-5 promulgated thereunder, as well as Section 20(a) of the Exchange Act. The Celeste lawsuit claimed compensatory damages and legal fees.

On May 14, 2021, a related class action lawsuit was filed in the United States District Court, Eastern District of Texas, Sherman Division, captioned Neely v. Intrusion Inc., et al., Case No. 4:12-cv-00374 (E.D. Tex.) against us, our now-former chief financial officer, and now-former chief executive officer. The Neely lawsuit alleged the same violations under the federal securities laws as those alleged in the Celeste lawsuit. The Neely lawsuit also sought compensatory damages and legal fees.

The parties to the consolidated class action held a mediation on April 5, 2022, at the conclusion of which the parties executed a settlement term sheet setting forth the material terms associated with the resolution of the action, subject to the preparation of formal documents and a plan of distribution approved by the Court. The settlement agreement was subject to certain terms and conditions and received final approval by the Court on December 16, 2022. At that time, a final judgement was entered dismissing the case, with the Court retaining jurisdiction over the action for purposes of enforcing the terms of the class settlement agreement. The $3.3 million settlement was paid by our insurance provider under our insurance policy as our retention had previously been exhausted.

Securities Investigation

On August 8, 2021, we received a notification from the Securities and Exchange Commission, Division of Enforcement, that it was conducting an investigation captioned In the Matter of Intrusion Inc. and requesting we produce certain documents and information. On November 9, 2021, the Securities and Exchange Commission served a subpoena to us in connection with this investigation which formally requested substantially similar information as in the prior request. We are continuing to comply with the requests and are cooperating in the investigation. We can offer no assurances as to the outcome of this investigation or its potential effect on us or our results of operations.

Stockholder Derivative Claim

On June 3, 2022, a stockholder derivative complaint was filed in U.S. District Court, District of Delaware by plaintiff Nathan Prawitt on behalf of Intrusion against certain of our current and former officers and directors. Plaintiff alleges that Defendants through various actions breached their fiduciary duties, wasted corporate assets, and unjustly enriched Defendants by (a) incurring costs and expenses in connection with the ongoing SEC investigation, (b) incurring costs and expenses to defend us with respect to the consolidated class action, (c) settling class-wide liability with respect to the consolidated class action, as well as ancillary claims regarding sales of our common stock by certain of the Defendants. The Plaintiff is seeking remedial actions including improvements in our corporate governance and internal control policies and reimbursement of legal costs. While we are not a named defendant, but a nominal plaintiff in the stockholder derivative claim, we will be providing the financial and other assistance for each of the Defendants that we are obligated to provide under our Articles of Incorporation, our Bylaws, as well as individual indemnifications agreements that are in effect between, us and each of the Defendants.

In addition to these legal proceedings, we are subject to various other claims that may arise in the ordinary course of business. We do not believe that any claims exist where the outcome of such matters would have a material adverse effect on our condensed consolidated financial position, operating results, or cash flows. However, there can be no assurance such legal proceedings will not have a material impact on our future results.

Item 1A. RISK FACTORS

In addition to the information set forth elsewhere in this Quarterly Report on Form 10-Q and the risk factor set forth below, you should carefully consider the risk factors we previously disclosed in our Annual Report on Form 10-K, filed with the SEC on March 31, 2023, as of and for the year ended December 31, 2022 (the “Annual Report”). These risks could materially and adversely affect our business, financial condition, results of operations, and cash flows. However, these risks are not the only risks we face. Additional risks and uncertainties not presently known to us or that we currently deem immaterial also may impair our business, financial condition, results of operations, and cash flows.

Risks Related to Our Financial Position and Liquidity

We may not be able to implement our current business plan or continue operations unless we are able to raise additional funds through public or private financings.

As of August 11, 2023, we had $0.3 million of cash, which is not sufficient to fund our monthly operating needs. We need to raise additional funds in the near term to continue operations and comply with our financial obligations. We intend to obtain these funds through one or more offerings of debt or equity securities, including through registered direct offerings, private placements, and the use of our at-the-market program. We can provide no assurances that we will be able to raise additional funds, and the terms of those financings, if available at all, may be on terms, which are not favorable to us and, in the case of equity financings, will result in dilution to our stockholders.

If we are unable to obtain additional debt or equity financing on acceptable terms, we may be unable to implement our business plan, fund our liquidity needs or even continue our operations. Specifically, we may have to further reduce our workforce, sell our assets, and reduce or cease activities to grow our business. Such actions may impact our ability to comply with the obligations under our commercial contracts, including those under the government contract for which we received prepayment of the full one-year term in April 2023. Failure to comply with such contracts may result in the termination of such contracts and us being obligated to return some or any prepayments we received. We may also fail to satisfy our obligations under the Streeterville notes.

Item 2. UNREGISTERED SALE OF SECURITIES AND USE OF PROCEEDS

On May 24, 2022, the Company issued 75,188 shares of its common stock pursuant to a transaction that qualified under section 4(2) as a transaction exempt from the registration requirements of the Securities Act of 1933, as amended. These shares were issued to Purple Plaza, LLC, as partial consideration for a confidential settlement agreement between the Company and Purple Plaza.

Item 6. EXHIBITS

The following Exhibits are filed with this report form 10-Q:

10.1	Amendment dated January 11, 2023, to the Securities Purchase Agreement dated March 10, 2022, by and between the Registrant and Streeterville Capital, LLC (incorporated by reference to Exhibit 10.1 of the Registrant’s Form 8-K filed on January 17, 2023)
10.2 10.3	Note Purchase Agreement dated February 23, 2023, dated February 23, 2023, by and Between Registrant and Streeterville Capital, LLC (incorporated by reference to Exhibit 10.1 of the Registrant’s Form 8-K filed on March 1, 2023) Amendment dated March 27, 2023, to the Omnibus Incentive Plan (incorporated by reference to Exhibit 10.1 to the Registrant’s Form 8-K filed on May 22, 2023)
31.1	Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) of the Exchange Act.
31.2	Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) of the Exchange Act.
32.1	Certification Pursuant to Rule 13a-14(b) of the Exchange Act and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Schema Document
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document
101.LAB	XBRL Taxonomy Extension Label Linkbase Document
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	INTRUSION INC.

Date: August 14, 2023	/s/ Anthony Scott
	Anthony Scott
	Director, President & Chief Executive Officer (Principal Executive Officer)



Date: August 14, 2023	/s/ Kimberly Pinson
	Kimberly Pinson
	Chief Financial Officer, (Principal Financial & Accounting Officer)

EXHIBIT 31.1

I, Anthony Scott, Principal Executive Officer of Intrusion Inc., certify that:

(1)

I have reviewed this quarterly report on Form 10-Q of Intrusion Inc.;

(2)

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

(3)

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

(4)

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

(5)

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 14, 2023	/s/ Anthony Scott
	Anthony Scott
	Chief Executive Officer

EXHIBIT 31.2

I, Kimberly Pinson, Chief Financial Officer of Intrusion Inc., certify that:

(1)

I have reviewed this quarterly report on Form 10-Q of Intrusion Inc.;

(2)

(3)

(4)

(a)

(b)

(c)

(d)

(5)

(a)

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 14, 2023	/s/ Kimberly Pinson
	Kimberly Pinson
	Chief Financial Officer

EXHIBIT 32

CERTIFICATION PURSUANT TO RULE 13a-14(b) OF THE EXCHANGE ACT AND 18 U.S.C. SECTION 1350, AS ENACTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Intrusion Inc. (the “Company”) on Form 10-Q, for the quarter ended June 30, 2023 (the “Report”) as filed with the Securities and Exchange Commission on the date hereof, each of the undersigned Officers of the Company does hereby certify, pursuant to 18 U.S.C. Section 1350, as enacted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

August 14, 2023	/s/ Anthony Scott
	Anthony Scott
	Chief Executive Officer

August 14, 2023	/s/ Kimberly Pinson
	Kimberly Pinson
	Chief Financial Officer

The foregoing certification is being furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and is not being filed as part of the Report or as a separate disclosure document.

Cover - shares	6 Months Ended
Cover - shares	Jun. 30, 2023	Aug. 11, 2023
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Jun. 30, 2023
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2023
Current Fiscal Year End Date	--12-31
Entity File Number	001-39608
Entity Registrant Name	INTRUSION INC.
Entity Central Index Key	0000736012
Entity Tax Identification Number	75-1911917
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	101 East Park Blvd
Entity Address, Address Line Two	Suite 1200
Entity Address, City or Town	Plano
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	75074
City Area Code	(972)
Local Phone Number	234-6400
Title of 12(b) Security	Common Stock, par value $0.01 per share
Trading Symbol	INTZ
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		23,134,011

CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Current Assets:
Cash and cash equivalents	$ 300	$ 3,015
Accounts receivable, net	211	530
Prepaid expenses and other assets	427	1,877
Total current assets	938	5,422
Property and equipment:
Equipment	2,886	2,865
Capitalized software development	2,196	1,380
Furniture and fixtures	43	43
Leasehold improvements	78	78
Property and equipment, gross	5,203	4,366
Accumulated depreciation and amortization	(2,674)	(2,208)
Property and equipment, net	2,529	2,158
Finance leases, right-of-use assets, net	715	1,048
Operating leases, right-of-use assets, net	348	504
Other assets	147	143
Total noncurrent assets	3,739	3,853
TOTAL ASSETS	4,677	9,275
Current Liabilities:
Accounts payable, trade	1,798	1,273
Accrued expenses	212	446
Finance lease liabilities, current portion	618	667
Operating lease liabilities, current portion	184	294
Notes payable	10,894	10,114
Deferred revenue	1,121	455
Total current liabilities	14,827	13,249
Noncurrent Liabilities:
Finance lease liabilities, noncurrent portion	4	10
Operating lease liabilities, noncurrent portion	167	231
Total noncurrent liabilities	171	241
Commitments and Contingencies – (See Note 5)
Stockholders’ Deficit:
Preferred stock, $0.01 par value: Authorized shares – 5,000 Issued shares – 0 in 2023 and 2022	0	0
Common stock, $0.01 par value: Authorized shares – 80,000; Issued shares – 22,442 in 2023 and 21,198 in 2022; Outstanding shares – 22,432 in 2023 and 21,188 in 2022	224	212
Common stock held in treasury, at cost – 10 shares	(362)	(362)
Additional paid-in capital	94,049	92,304
Accumulated deficit	(104,189)	(96,326)
Accumulated other comprehensive loss	(43)	(43)
Total stockholders’ deficit	(10,321)	(4,215)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT	$ 4,677	$ 9,275

CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical) - $ / shares shares in Thousands	Jun. 30, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Preferred Stock, Par or Stated Value Per Share	$ 0.01	$ 0.01
Preferred Stock, Shares Authorized	5,000	5,000
Preferred Stock, Shares Issued	0	0
Common Stock, Par or Stated Value Per Share	$ 0.01	$ 0.01
Common Stock, Shares Authorized	80,000	80,000
Common Stock, Shares, Issued	22,442	21,198
Common Stock, Shares, Outstanding	22,432	21,188
Common stock held in treasury, at cost, shares (in shares)	10	10

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Income Statement [Abstract]
Revenue	$ 1,468	$ 2,058	$ 2,777	$ 3,893
Cost of revenue	330	916	643	1,819
Gross profit	1,138	1,142	2,134	2,074
Operating expenses:
Sales and marketing	1,423	1,568	3,161	2,774
Research and development	1,451	1,486	3,247	3,136
General and administrative	1,185	2,049	2,691	4,109
Operating loss	(2,921)	(3,961)	(6,965)	(7,945)
Interest and other income	0	1	41	2
Interest expense	(208)	(525)	(939)	(596)
Gain on lease termination	0	420	0	420
Net loss	$ (3,129)	$ (4,065)	$ (7,863)	$ (8,119)
Net loss per share:
Basic	$ (0.15)	$ (0.21)	$ (0.37)	$ (0.42)
Diluted	$ (0.15)	$ (0.21)	$ (0.37)	$ (0.42)
Weighted average common shares outstanding:
Basic	21,383	19,372	21,225	19,238
Diluted	21,383	19,372	21,225	19,238

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($) shares in Thousands, $ in Thousands	Common Stock [Member]	Treasury Stock, Common [Member]	AOCI Attributable to Parent [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Dec. 31, 2021	$ 191	$ (362)	$ (43)	$ 84,230	$ (80,097)	$ 3,919
Beginning Balance, shares at Dec. 31, 2021	19,135	10
Stock-based compensation expense				427		427
Exercise of stock options	$ 1			60		61
Exercise of stock options, shares	91
Public stock offering, net of fees	$ 3			946		949
Public stock offering, net of fees, shares	248
Net loss					(4,054)	(4,054)
Ending balance, value at Mar. 31, 2022	$ 195	$ (362)	(43)	85,663	(84,151)	1,302
Ending Balance, shares at Mar. 31, 2022	19,474	10
Beginning balance, value at Dec. 31, 2021	$ 191	$ (362)	(43)	84,230	(80,097)	3,919
Beginning Balance, shares at Dec. 31, 2021	19,135	10
Net loss						(8,119)
Ending balance, value at Jun. 30, 2022	$ 197	$ (362)	(43)	86,570	(88,216)	(1,854)
Ending Balance, shares at Jun. 30, 2022	19,745	10
Beginning balance, value at Mar. 31, 2022	$ 195	$ (362)	(43)	85,663	(84,151)	1,302
Beginning Balance, shares at Mar. 31, 2022	19,474	10
Stock-based compensation expense				450		450
Exercise of stock options				4		4
Exercise of stock options, shares	6
Public stock offering, net of fees	$ 1			254		255
Public stock offering, net of fees, shares	84
Net loss					(4,065)	(4,065)
Partial extinguishment of operating lease with common stock				200		200
Partial extinguishment of operating lease with common stock, shares	75
Issuance of restricted stock, net of forfeitures	$ 1			(1)
Restricted stock, net of current forfeitures, shares	106
Ending balance, value at Jun. 30, 2022	$ 197	$ (362)	(43)	86,570	(88,216)	(1,854)
Ending Balance, shares at Jun. 30, 2022	19,745	10
Beginning balance, value at Dec. 31, 2022	$ 212	$ (362)	(43)	92,304	(96,326)	(4,215)
Beginning Balance, shares at Dec. 31, 2022	21,198	10
Stock-based compensation expense				94		94
Exercise of stock options				7		7
Exercise of stock options, shares	58
Public stock offering, net of fees				21		21
Public stock offering, net of fees, shares	2
Withholdings related to stock-based compensation awards				(5)		(5)
Net loss					(4,734)	(4,734)
Ending balance, value at Mar. 31, 2023	$ 212	$ (362)	(43)	92,421	(101,060)	(8,832)
Ending Balance, shares at Mar. 31, 2023	21,258	10
Beginning balance, value at Dec. 31, 2022	$ 212	$ (362)	(43)	92,304	(96,326)	(4,215)
Beginning Balance, shares at Dec. 31, 2022	21,198	10
Net loss						(7,863)
Ending balance, value at Jun. 30, 2023	$ 224	$ (362)	(43)	94,049	(104,189)	(10,321)
Ending Balance, shares at Jun. 30, 2023	22,442	10
Beginning balance, value at Mar. 31, 2023	$ 212	$ (362)	(43)	92,421	(101,060)	(8,832)
Beginning Balance, shares at Mar. 31, 2023	21,258	10
Stock-based compensation expense				331		331
Public stock offering, net of fees	$ 10			1,299		1,309
Public stock offering, net of fees, shares	970
Net loss					(3,129)	(3,129)
Issuance of restricted stock, net of forfeitures	$ 2			(2)
Issuance of restricted stock, net of forfeitures, shares	214
Ending balance, value at Jun. 30, 2023	$ 224	$ (362)	$ (43)	$ 94,049	$ (104,189)	$ (10,321)
Ending Balance, shares at Jun. 30, 2023	22,442	10

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Operating Activities:
Net loss	$ (7,863)	$ (8,119)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	798	616
Bad debt expense	48	0
Stock-based compensation	425	876
Non-cash lease costs	156	150
Amortization of debt issuance costs	555	133
Non-cash interest and interest accretion up to the redemption common stock settlement amount	225	306
Gain on lease termination	0	(420)
Changes in operating assets and liabilities:
Accounts receivable	271	(255)
Prepaid expenses and other assets	1,446	(425)
Accounts payable and accrued expenses	172	141
Operating lease liabilities	(174)	(882)
Deferred revenue	666	754
Net cash used in operating activities	(3,275)	(7,125)
Investing Activities:
Capitalization of software development	(692)	(350)
Purchases of property and equipment	(25)	(126)
Net cash used in investing activities	(717)	(476)
Financing Activities:
Proceeds from notes payable	0	10,000
Payment on notes payable issuance costs	0	(710)
Proceeds from stock options exercised	7	66
Proceeds from public stock offering net of fees	1,330	1,204
Withholdings related to stock-based compensation awards	(5)	0
Reduction of finance lease liability	(55)	(41)
Net cash provided by financing activities	1,277	10,519
Net (decrease) increase in cash and cash equivalents	(2,715)	2,918
Cash and cash equivalents at beginning of period	3,015	4,100
Cash and cash equivalents at end of period	300	7,018
SUPPLEMENTAL DISCLOSURE OF CASH FLOW ACTIVITIES:
Cash paid for interest	159	0
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Common stock issued for lease termination	0	200
Equipment purchases and capitalized software included in accounts payable	$ 119	$ 0

Description of Business

6 Months Ended

Jun. 30, 2023

Accounting Policies [Abstract]

Description of Business

1. Description of Business

Basis of Presentation

6 Months Ended

Jun. 30, 2023

Accounting Policies [Abstract]

Basis of Presentation

2. Basis of Presentation

Going Concern

Right-of-use Asset and Leasing Liabilities

6 Months Ended

Jun. 30, 2023

Right-of-use Asset And Leasing Liabilities

Right-of-use Asset and Leasing Liabilities

3. Right-of-use Asset and Leasing Liabilities

Schedule of Items Appearing on the Condensed Consolidated Statement of Operations (in thousands):

Lease cost table
	Three Months Ended				Six Months Ended
	June 30, 2023		June 30, 2022		June 30, 2023		June 30, 2022
Operating expense:
Amortization expense – Finance ROU	$	167	$	166	$	333	$	332
Lease expense – Operating ROU	$	79	$	91	$	156	$	186
Other expense:
Interest expense – Finance ROU	$	5	$	15	$	11	$	22

Future minimum lease obligations consisted of the following as of June 30, 2023 (in thousands):

Future minimum lease obligations
	Operating			Finance
Period ending December 31,	ROU Leases			ROU Leases			Total
2023		127			615			742
2024		123			8			131
2025		115			3			118
	$	365		$	626		$	991
Less Interest*		(14	)		(4	)
	$	351		$	622

*	Interest is imputed for operating ROU leases and classified as lease expense and is included in operating expenses in the accompanying Condensed Consolidated Statement of Operations.

Notes Payable

6 Months Ended

Jun. 30, 2023

Debt Disclosure [Abstract]

Notes Payable

4. Notes Payable

Commitments and Contingencies

6 Months Ended

Jun. 30, 2023

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

5. Commitments and Contingencies

Class Action Litigation

Securities Investigation

Stockholder Derivative Claim

Common Stock

6 Months Ended

Jun. 30, 2023

Equity [Abstract]

Common Stock

6. Common Stock

ATM Offering

Registered Direct Offering

Stock-Based Compensation

6 Months Ended

Jun. 30, 2023

Share-Based Payment Arrangement [Abstract]

Stock-Based Compensation

7. Stock-Based Compensation

The following table summarizes the activities for the Company’s stock options for the six months ended June 30, 2023:

Schedule of stock option activities
	June 30, 2023
	Number of Options			Weighted Average
	(In thousands)			Exercise Price
Outstanding at beginning of year		668		$	5.22
Granted		626			1.25
Exercised		(72	)		0.48
Forfeited		(167	)		4.37
Expired		(42	)		8.19
Outstanding on June 30, 2023		1,013		$	3.12
Options exercisable on June 30, 2023		368		$	4.61

Valuation Assumptions

The fair values of employee option awards were estimated at the date of grant using a Black-Scholes option-pricing model with the following assumptions:


	For Three Months Ended June 30, 2023		For Three Months Ended June 30, 2022		For Six Months Ended June 30, 2023		For Six Months Ended June 30, 2022
Weighted average grant date fair value	$	1.09	$	–	$	1.08	$	3.34
Weighted average assumptions used:
Expected dividend yield		0.0%		0.0%		0.0%		0.0%
Risk-free interest rate		3.53%		0.0%		3.68%		0.88%
Expected volatility		103.2%		0.0%		114.1%		133.0%
Expected life (in years)		6.4		–		6.4		6.6

Revenue Recognition

6 Months Ended

Jun. 30, 2023

Revenue from Contract with Customer [Abstract]

Revenue Recognition

8. Revenue Recognition

	i)	identification of the contract with a customer;

	ii)	identification of the performance obligations in the contract;

	iii)	determination of the transaction price;

	iv)	allocation of the transaction price to each separate performance obligations; and

	v)	recognition of revenue upon satisfaction of a performance obligation.

	·	Access to Intrusion’s proprietary software and database to detect and prevent unauthorized access to its clients’ information networks;

	·	Use of all software, associated media, printed materials, data, files, online documentation, and any equipment that Intrusion provides for customers to access the INTRUSION Shield; and

	·	Tech support, post contract customer support (PCS) includes daily program releases or corrections provided by Intrusion without additional charge.

INTRUSION Shield

Contracts provide for no other services, and our customers have no rebates or return rights, nor are any such rights anticipated to be offered as part of this service.

We had no material contract assets as of June 30, 2023, and December 31, 2022.

The following table presents changes in the Company’s contract liability during the six months ended June 30, 2023, and the year ended December 31, 2022 (in thousands):

Schedule of contract liability
	June 30, 2023			December 31, 2022
Balance at beginning of period	$	455		$	560
Additions		2,047			1,877
Revenue recognized		(1,381	)		(1,982	)
Balance at end of period	$	1,121		$	455

Capitalized Software Development

6 Months Ended

Jun. 30, 2023

Extractive Industries [Abstract]

Capitalized Software Development

9. Capitalized Software Development

Net Loss Per Share

6 Months Ended

Jun. 30, 2023

Earnings Per Share [Abstract]

Net Loss Per Share

10. Net Loss Per Share

Correction of Immaterial Error

6 Months Ended

Jun. 30, 2023

Correction Of Immaterial Error

Correction of Immaterial Error

11. Correction of Immaterial Error

The below tables present (in thousands) the effect of the correction for the following periods:

Schedule of effect of the correction
	Three Months Ended June 30, 2022
	As Reported			Adjustments			As Corrected
Revenue	$	2,058		$	–		$	2,058
Cost of revenue		667			249			916

Gross profit		1,391			(249	)		1,142

Operating expenses
Sales and marketing		1,817			(249	)		1,568
Research and development		1,486			–			1,486
General and administrative		2,049			–			2,049

Operating loss	$	(3,961	)	$	–		$	(3,961	)


	Six Months Ended June 30, 2022
	As Reported			Adjustments			As Corrected
Revenue	$	3,893		$	–		$	3,893
Cost of revenue		1,321			498			1,819

Gross profit		2,572			(498	)		2,074

Operating expenses
Sales and marketing		3,272			(498	)		2,774
Research and development		3,136			–			3,136
General and administrative		4,109			–			4,109

Operating loss	$	(7,945	)	$	–		$	(7,945	)

Subsequent Event

6 Months Ended

Jun. 30, 2023

Subsequent Events [Abstract]

Subsequent Event

12. Subsequent Event

Right-of-use Asset and Leasing Liabilities (Tables)

6 Months Ended

Jun. 30, 2023

Right-of-use Asset And Leasing Liabilities

Lease cost table

Lease cost table
	Three Months Ended				Six Months Ended
	June 30, 2023		June 30, 2022		June 30, 2023		June 30, 2022
Operating expense:
Amortization expense – Finance ROU	$	167	$	166	$	333	$	332
Lease expense – Operating ROU	$	79	$	91	$	156	$	186
Other expense:
Interest expense – Finance ROU	$	5	$	15	$	11	$	22

Future minimum lease obligations

Future minimum lease obligations
	Operating			Finance
Period ending December 31,	ROU Leases			ROU Leases			Total
2023		127			615			742
2024		123			8			131
2025		115			3			118
	$	365		$	626		$	991
Less Interest*		(14	)		(4	)
	$	351		$	622

*	Interest is imputed for operating ROU leases and classified as lease expense and is included in operating expenses in the accompanying Condensed Consolidated Statement of Operations.

Stock-Based Compensation (Tables)

6 Months Ended

Jun. 30, 2023

Share-Based Payment Arrangement [Abstract]

Schedule of stock option activities

Schedule of stock option activities
	June 30, 2023
	Number of Options			Weighted Average
	(In thousands)			Exercise Price
Outstanding at beginning of year		668		$	5.22
Granted		626			1.25
Exercised		(72	)		0.48
Forfeited		(167	)		4.37
Expired		(42	)		8.19
Outstanding on June 30, 2023		1,013		$	3.12
Options exercisable on June 30, 2023		368		$	4.61

Valuation assumptions for stock-based compensation


	For Three Months Ended June 30, 2023		For Three Months Ended June 30, 2022		For Six Months Ended June 30, 2023		For Six Months Ended June 30, 2022
Weighted average grant date fair value	$	1.09	$	–	$	1.08	$	3.34
Weighted average assumptions used:
Expected dividend yield		0.0%		0.0%		0.0%		0.0%
Risk-free interest rate		3.53%		0.0%		3.68%		0.88%
Expected volatility		103.2%		0.0%		114.1%		133.0%
Expected life (in years)		6.4		–		6.4		6.6

Revenue Recognition (Tables)

6 Months Ended

Jun. 30, 2023

Revenue from Contract with Customer [Abstract]

Schedule of contract liability

Schedule of contract liability
	June 30, 2023			December 31, 2022
Balance at beginning of period	$	455		$	560
Additions		2,047			1,877
Revenue recognized		(1,381	)		(1,982	)
Balance at end of period	$	1,121		$	455

Correction of Immaterial Error (Tables)

6 Months Ended

Jun. 30, 2023

Correction Of Immaterial Error

Schedule of effect of the correction

Schedule of effect of the correction
	Three Months Ended June 30, 2022
	As Reported			Adjustments			As Corrected
Revenue	$	2,058		$	–		$	2,058
Cost of revenue		667			249			916

Gross profit		1,391			(249	)		1,142

Operating expenses
Sales and marketing		1,817			(249	)		1,568
Research and development		1,486			–			1,486
General and administrative		2,049			–			2,049

Operating loss	$	(3,961	)	$	–		$	(3,961	)


	Six Months Ended June 30, 2022
	As Reported			Adjustments			As Corrected
Revenue	$	3,893		$	–		$	3,893
Cost of revenue		1,321			498			1,819

Gross profit		2,572			(498	)		2,074

Operating expenses
Sales and marketing		3,272			(498	)		2,774
Research and development		3,136			–			3,136
General and administrative		4,109			–			4,109

Operating loss	$	(7,945	)	$	–		$	(7,945	)

Basis of Presentation (Details Narrative) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Jun. 30, 2023
Debt Instrument [Line Items]
Cash and cash equivalents		$ 300
Working capital		$ 13,900
Common Stock And Warrants [Member]
Debt Instrument [Line Items]
Proceeds from Issuance or Sale of Equity	$ 6,400
Two Streeterville Notes [Member]
Debt Instrument [Line Items]
Proceeds from Notes Payable	$ 9,300

Right-of-use Asset and Leasing Liabilities (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Operating expense:
Amortization expense – Finance ROU	$ 167	$ 166	$ 333	$ 332
Lease expense – Operating ROU	79	91	156	186
Other expense:
Interest expense – Finance ROU	$ 5	$ 15	$ 11	$ 22

Right-of-use Asset and Leasing Liabilities (Details - Minimum lease obligation)
$ in Thousands

Jun. 30, 2023

USD ($)

Operating and Finance total lease minimum obligation - Remaining 2023

$ 742

Operating and Finance total lease minimum obligation - 2024

131

Operating and Finance total lease minimum obligation - 2025

118

Operating and Finance total lease minimum obligation liability,

991

Operating ROU Leases [Member]

Remaining 2023

127

Operating ROU Leases, 2024

123

Operating ROU Leases, 2025

115

Operating ROU Leases Undiscounted Obligation

365

Operating ROU Leases, Less Interest

(14)

^[1]

Operating ROU Leases

351

Finance ROU Leases [Member]

Remaining 2023

615

Finance ROU Leases, 2024

Finance ROU Leases, 2025

Finance ROU Leases Undiscounted Obligation

626

Finance ROU Leases, Less Interest

(4)

^[1]

Finance ROU Leases

$ 622

[1]	Interest is imputed for operating ROU leases and classified as lease expense and is included in operating expenses in the accompanying Condensed Consolidated Statement of Operations.

Right-of-use Asset and Leasing Liabilities (Details Narrative) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2023
Right-of-use Asset And Leasing Liabilities
Operating Lease, Payments	$ 100	$ 200
Financing Lease	$ 41	$ 55

Notes Payable (Details Narrative) - USD ($)			3 Months Ended	6 Months Ended
Notes Payable (Details Narrative) - USD ($)	Jun. 29, 2022	Mar. 10, 2022	Jun. 30, 2023	Jun. 30, 2023
Securities Financing Transaction [Line Items]
Proceeds from issuance of public offering				$ 5,000,000
Debt interest expense			$ 200,000	800,000
Streeterville Capital [Member]
Securities Financing Transaction [Line Items]
Proceeds from issuance of notes	$ 4,700,000	$ 4,600,000
Debt issuance costs			$ 400,000	400,000
Cash payments				$ 50,000,000
Debt Issuance Costs, Gross		$ 1,800,000
Effective interest rate			14.80%	14.80%

Common Stock (Details Narrative) - ATM Offering [Member] shares in Thousands, $ in Thousands	6 Months Ended
	Jun. 30, 2023 USD ($) shares
Securities Financing Transaction [Line Items]
Proceeds from issuance of common stock \| $	$ 8,900
Issuance of common stock \| shares	2,800

Stock-Based Compensation (Details - Stock option activities) shares in Thousands	6 Months Ended
	Jun. 30, 2023 $ / shares shares
Share-Based Payment Arrangement [Abstract]
Number of Options Outstanding, beginning \| shares	668
Weighted Average Exercise Price Outstanding at beginning \| $ / shares	$ 5.22
Number of Options, Granted \| shares	626
Weighted Average Exercise Price Granted \| $ / shares	$ 1.25
Number of Options, Exercised \| shares	(72)
Weighted Average Exercise Price Exercised \| $ / shares	$ 0.48
Number of Options, Forfeited \| shares	(167)
Weighted Average Exercise Price Forfeited \| $ / shares	$ 4.37
Number of Options, Expired \| shares	(42)
Weighted Average Exercise Price Expired \| $ / shares	$ 8.19
Number of Options Outstanding, ending \| shares	1,013
Weighted Average Exercise Price Outstanding at Ending balance \| $ / shares	$ 3.12
Number of Options, Exercisable \| shares	368
Weighted Average Exercise Price, Exercisable \| $ / shares	$ 4.61

Accounting for Stock-Based Compensation (Details - Valuation Assumptions) - $ / shares	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Share-Based Payment Arrangement [Abstract]
Weighted average grant date fair value	$ 1.09	$ 0	$ 1.08	$ 3.34
Expected dividend yield	0.00%	0.00%	0.00%	0.00%
Risk-free interest rate	3.53%	0.00%	3.68%	0.88%
Expected volatility	103.20%	0.00%	114.10%	133.00%
Expected life (in years) (Year)	6 years 4 months 24 days		6 years 4 months 24 days	6 years 7 months 6 days

Stock-Based Compensation (Details Narrative) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock-based compensation expense			$ 425	$ 876
Restricted Stock Awards [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock options granted			213,700	131,600
Stock-based compensation expense	$ 100	$ 100	$ 200	$ 300
Unrecognized compensation cost not yet recognized, amount	300		$ 300
Stock Option Awards [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock options granted			626,400	167,500
Stock-based compensation expense	200	$ 400	$ 200	$ 600
Unrecognized compensation cost not yet recognized, amount	$ 600		$ 600

Revenue Recognition (Details) - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
Revenue Recognition (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Revenue from Contract with Customer [Abstract]
Contract liability, Beginning	$ 455	$ 560
Additions	2,047	1,877
Contract liabilities revenue recognized	(1,381)	(1,982)
Contract liability, Ending	$ 1,121	$ 455

Revenue Recognition (Details Narrative) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Revenue from Contract with Customer [Abstract]
Accounts Receivable	$ 200	$ 500
Allowance of doubtful accounts	42	0
Contract assets	$ 0	$ 0

Net Loss Per Share (Details Narrative) - shares shares in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Earnings Per Share [Abstract]
Antidilutive shares	2,497	611	2,278	629

Correction of Immaterial Error (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Gross profit	$ 1,138	$ 1,142	$ 2,134	$ 2,074
Operating expenses
Sales and marketing	1,423	1,568	3,161	2,774
Research and development	1,451	1,486	3,247	3,136
General and administrative	1,185	2,049	2,691	4,109
Operating loss	$ (2,921)	(3,961)	$ (6,965)	(7,945)
Previously Reported [Member]
Revenue		2,058		3,893
Cost of revenue		667		1,321
Gross profit		1,391		2,572
Operating expenses
Sales and marketing		1,817		3,272
Research and development		1,486		3,136
General and administrative		2,049		4,109
Operating loss		(3,961)		(7,945)
Revision of Prior Period, Adjustment [Member]
Revenue		0		0
Cost of revenue		249		498
Gross profit		(249)		(498)
Operating expenses
Sales and marketing		(249)		(498)
Research and development		0		0
General and administrative		0		0
Operating loss		0		0
As Corrected [Member]
Revenue		2,058		3,893
Cost of revenue		916		1,819
Gross profit		1,142		2,074
Operating expenses
Sales and marketing		1,568		2,774
Research and development		1,486		3,136
General and administrative		2,049		4,109
Operating loss		$ (3,961)		$ (7,945)